A director at Indutrade AB bought 160,000 shares at 260.657SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Q1 earnings disappointed, but sales grew 0.3% YOY (ending 5% above consensus), including 0.2% organic, marking the first positive figure since autumn 2023. EBITA was SEK123m (12% below consensus), corresponding to a margin of 3.7%, while the adj. EBITA margin was 5.7%. Cash from operating activities was good, driven by a working capital release. We have cut our 2025e EBITA by 7% and 2026e by 4%, and lowered our target price to SEK45 (46), but reiterate our BUY.
Sales grew 4% (consensus 6%) in Q1, of which organic growth was flat, while EBITA missed consensus by 6% and EPS by 9%. Process, Energy & Water saw the biggest deviation, partly explained by lower sales in comparable units and higher costs. The group EBITA margin was up 30bp YOY to 13.6% (consensus 14.2%). We have lowered our 2025–2026e EBITA by 6–2%, and our target price to SEK295 (300), while we reiterate our HOLD.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.